Santé log

Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD

Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...
Santé log

Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”) today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the “Issuer”), priced $425.0 million ...
Santé log

Merakris Therapeutics Chief Scientific Officer Dr. Roger Ilagan to Present at Innovations in Wound Healing Symposium

“The Innovations in Wound Healing Symposium is an important venue for advancing the scientific conversation in our field,” said Dr. Roger Ilagan, Chief Scientific Officer at Merakris Therapeutics. “I ...
Santé log

MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates

According to management, statistical assessments of the Phase 3 trial points to a very high probability of technical success for regulatory approval of ateganosine. The U.S. Food and Drug ...
Santé log

Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

This press release shall not constitute an offer to sell, or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which ...
Santé log

Structure Therapeutics Announces Closing of Upsized $747.5 Million Public Offering of ADSs and Pre-Funded Warrants and Full Exercise of the Underwriters’ Option to Purchase ...

Jefferies, Leerink Partners, Goldman Sachs & Co. LLC, Morgan Stanley, Guggenheim Securities and BMO Capital Markets acted as joint book-running managers for the offering. LifeSci Capital and Citizens ...
Santé log

Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala

SEATTLE, Dec. 11, 2025 (GLOBE NEWSWIRE) -- In late November more than 400 community members gathered in Fremont for the SOUND of Hope Gala, SOUND Behavioral Health’s annual fundraiser to expand access ...
Santé log

Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the ...
Santé log

Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Terns Pharmaceuticals is a clinical-stage oncology company reimagining known biology to deliver high impact medicines. Our lead program TERN-701 is a highly selective, allosteric BCR-ABL inhibitor ...
Santé log

BBOT Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

(“BBOT”) (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced it awarded an inducement grant on December 10, 2025 under BBOT’s 2025 ...
Santé log

The Joint Corp. Signs Asset Purchase Agreement to Sell 22 Corporate Clinics in the Southeast and Delivers Notice to Terminate APA for 45 Clinics in California

Southeast Buyers are Existing Members of the Franchise Community, Further Increasing their Ownership. SCOTTSDALE, Ariz., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: ...
Santé log

SEMCAP Health Leads $25 Million Series D Investment in SafeinHome

SafeinHome, the nation’s leader in Remote Supports for individuals with intellectual and developmental disabilities (I/DD), today announced the successful first close as part of its targeted $25 ...